Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rangering i aksjer #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aksjekurs
$29.86
Sist synkronisert: 2026-08-19
Markedsverdi
$2.48B
Endring (1 dag)
4.92%
Endring (1 år)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Kategori

Historikk for aksjesplitt for Lin BioScience, Inc. (6696)
Aksjen Lin BioScience, Inc. (symbol: 6696) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 27, 2026.
Én 6696-aksje kjøpt før Aug 27, 2026 tilsvarer i dag 0 6696-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH